Allspring Global Investments Holdings LLC Invests $26,000 in Clover Health Investments, Corp. (NASDAQ:CLOV)

Allspring Global Investments Holdings LLC purchased a new stake in Clover Health Investments, Corp. (NASDAQ:CLOVFree Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 24,209 shares of the company’s stock, valued at approximately $26,000.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Clover Health Investments by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 26,087,528 shares of the company’s stock valued at $92,611,000 after acquiring an additional 200,177 shares during the period. BlackRock Inc. lifted its position in shares of Clover Health Investments by 5.9% during the 3rd quarter. BlackRock Inc. now owns 25,887,235 shares of the company’s stock valued at $44,009,000 after acquiring an additional 1,452,210 shares during the period. Renaissance Technologies LLC lifted its position in shares of Clover Health Investments by 29.2% during the 2nd quarter. Renaissance Technologies LLC now owns 8,847,780 shares of the company’s stock valued at $7,937,000 after acquiring an additional 1,999,380 shares during the period. State Street Corp lifted its holdings in shares of Clover Health Investments by 2.6% in the 3rd quarter. State Street Corp now owns 8,155,795 shares of the company’s stock worth $13,865,000 after purchasing an additional 205,043 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Clover Health Investments by 4.3% during the 1st quarter. Geode Capital Management LLC now owns 6,905,301 shares of the company’s stock valued at $5,836,000 after purchasing an additional 287,443 shares in the last quarter. Institutional investors own 19.95% of the company’s stock.

Clover Health Investments Stock Up 2.3 %

CLOV stock opened at $0.96 on Wednesday. The stock’s 50 day moving average is $0.97 and its 200-day moving average is $1.07. Clover Health Investments, Corp. has a twelve month low of $0.71 and a twelve month high of $1.63. The firm has a market capitalization of $470.18 million, a PE ratio of -2.01 and a beta of 1.91.

Clover Health Investments (NASDAQ:CLOVGet Free Report) last issued its quarterly earnings results on Monday, November 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.01. The company had revenue of $482.07 million during the quarter, compared to analyst estimates of $491.30 million. Clover Health Investments had a negative net margin of 9.37% and a negative return on equity of 75.65%. On average, equities research analysts anticipate that Clover Health Investments, Corp. will post -0.48 earnings per share for the current fiscal year.

Clover Health Investments Profile

(Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses.

See Also

Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOVFree Report).

Institutional Ownership by Quarter for Clover Health Investments (NASDAQ:CLOV)

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.